CROI 2024:艾滋病毒感染者的结核病,Mopox和其他传染性并发症
Andrew D Kerkhoff1, Jason Zucker2, Diane V Havlir1
1University of California San Francisco, San Francisco, California, USA.
Topics in antiviral medicine
|August 14, 2024
概括
新的抗结核药物显示出希望,但结核疫苗未能预防复发,而短时间的克洛法齐明治疗方案也没有成功. 本综述涵盖了2024年CROI会议对结核病和艾滋病毒相关感染的关键见解.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 结核病 (TB) 仍然是一个全球性卫生挑战,需要新的治疗和预防策略.
- 了解结核病,mopox和其他与艾滋病毒相关的机会性感染的进展对于有效的患者管理至关重要.
- 最近的科学会议提供了关于最新研究成果和临床发展的关键更新.
研究的目的:
- 在2024年复原病毒和机会性感染 (CROI) 会议上提出的结核病,mopox和艾滋病毒相关的传染性并发症的临床专注见解.
- 为提供对新型抗结核剂有前途的临床前和早期临床发现的概述.
- 突出结核病疫苗有效性和短期治疗方案的挫折.
主要方法:
- 审查了2024年复原病毒和机会性感染会议 (CROI) 的演讲和数据.
- 对新型抗结核剂的临床前和早期临床研究结果的分析.
- 对结核疫苗和3个月的克洛法齐明治疗方案的结果的评估.
主要成果:
- 一些新的抗结核药物,包括长效注射剂,在临床前和早期临床研究中显示出有前途.
- 结核病疫苗在临床试验中未能防止疾病复发.
- 一个为期3个月的基于clofazimine的药物敏感结核病治疗方案被发现是不成功的.
结论:
- 尽管有前途的新型抗结核药物,但结核病预防和治疗仍然存在挑战,这是疫苗和短期疗法失败所表明的.
- 2024年CROI会议强调了结核病,mopox和其他艾滋病毒相关感染的管理中的关键进展和持续挑战.
- 持续的研究和临床评估对于克服打击结核病和相关机会性感染的障碍至关重要.
更多相关视频
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
21.0K
08:14An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
10.3K
相关概念视频
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
Pulmonary Tuberculosis III
316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
316
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pneumonia I: Introduction
215
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
215
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
